Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 145

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 6
Chunk 145
---
 Code

This
summary does not address all aspects of U. S. federal income taxation that may be relevant to particular U. S. Holders in light of their
specific circumstances (for example, U. S. Holders subject to the alternative minimum tax or the Medicare contribution tax on net investment
income under the Code) or to holders that may be subject to special rules under U. S. federal income tax law, including:

  dealers                                                                                                                              
  securities                                                                                                                           
  banks                                                                                                                                
  insurance                                                                                                                            
  regulated                                                                                                                            
  real                                                                                                                                 
  tax-exempt                                                                                                                           
  retirement                                                                                                                           
  partnerships                                                                                                                         
  persons                                                                                                                              
  persons                                                                                                                              
  persons                                                                                                                              
  direct,                                                                                                                              

This
summary also does not address the tax consequences of holding, exercising or disposing of warrants in the Company. If the Company is
a PFIC, as described below, U. S. Holders of its warrants will be subject to adverse tax rules and will not be able to make the mark-to-market
or the QEF election described below with respect to such warrants. U. S. Holders of warrants should consult their tax advisors with regard
to the U. S. federal income tax consequences of holding, exercising or disposing of warrants in the Company, including in the situation
in which the Company is classified as a PFIC.

  98  

This
summary also does not discuss any aspect of state, local or foreign law, or estate or gift tax law as applicable to U. S. Holders. In
addition, this discussion is limited to U. S. Holders holding Common Shares as capital assets. For purposes of this summary, “ U. S.
Holder” means a beneficial holder of Common Shares who or that for U. S. federal income tax purposes is:

  an                                                                                                                                    
  a                                                                                                                                     
  an                                                                                                                                    
  a                                                                                                                                     

If
a partnership or other entity or arrangement classified as a partnership for U. S. federal income tax purposes holds Common Shares, the
U. S. federal income tax treatment of a partner generally will depend on the status of the partner and the activities of the partnership.
This summary does not address the tax consequences to any such partner. Such a partner should consult its own tax advisor as to the tax
consequences of the partnership purchasing, owning and disposing of Common Shares.

U. S.
HOLDERS SHOULD CONSULT THEIR OWN TAX ADVISORS WITH REGARD TO THE